|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
For human use
|
|
Package code:
|
1213074
|
|
Name of medicinal product:
|
AZOPT
|
|
Active substances:
|
|
|
ATC code:
|
S01EC04
|
|
Dosage form:
|
eye drops, suspension
|
|
Route of administration:
|
ocular use
|
|
Strengh:
|
10mg 1ml
|
|
Amount in package:
|
10ml 1TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
AZOPT is indicated to decrease elevated intraocular pressure in:
-ocular hypertension
-open-angle glaucoma
as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are
contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues.
|
|
Safety features:
|
Yes
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Last imported to Estonia:
|
Never imported to Estonia
|
|
Marketing authorization holder:
|
Novartis Europharm Limited
|
|
Marketing authorization number:
|
EU/1/00/129
|
|
Marketing authorization issued on:
|
March 10, 2000
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
Centralised
|
|
Reference price:
|
|
|
Under reference price:
|
|
|
Reference price of daily dose:
|
|
Entry/Changing date:
April 25, 2018
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere